GLP1R agonists (GLP1RA) are widely used in the treatment of diabetes and obesity, yet visualizing the endogenous localization, organization and dynamics of a GPCR has so far remained out of reach. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.